220 related articles for article (PubMed ID: 12089345)
1. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.
Hodgson MC; Astapova I; Cheng S; Lee LJ; Verhoeven MC; Choi E; Balk SP; Hollenberg AN
J Biol Chem; 2005 Feb; 280(8):6511-9. PubMed ID: 15598662
[TBL] [Abstract][Full Text] [Related]
3. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
Stevens A; Garside H; Berry A; Waters C; White A; Ray D
Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
[TBL] [Abstract][Full Text] [Related]
5. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.
Hodgson MC; Shen HC; Hollenberg AN; Balk SP
Mol Cancer Ther; 2008 Oct; 7(10):3187-94. PubMed ID: 18852122
[TBL] [Abstract][Full Text] [Related]
7. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
8. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
Makowski A; Brzostek S; Cohen RN; Hollenberg AN
Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
[TBL] [Abstract][Full Text] [Related]
9. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
Cohen RN; Wondisford FE; Hollenberg AN
Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
[TBL] [Abstract][Full Text] [Related]
10. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
[TBL] [Abstract][Full Text] [Related]
11. Anti-androgen effects of the pyrethroid pesticide cypermethrin on interactions of androgen receptor with corepressors.
Pan C; Wang Q; Liu YP; Xu LF; Li YF; Hu JX; Jiang M; Zhang JP; Zhang MR; Yu HM; Zhou JL; Zhou XL; Xu LC
Toxicology; 2013 Sep; 311(3):178-83. PubMed ID: 23831764
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
13. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase.
Jeong BC; Hong CY; Chattopadhyay S; Park JH; Gong EY; Kim HJ; Chun SY; Lee K
Mol Endocrinol; 2004 Jan; 18(1):13-25. PubMed ID: 14576337
[TBL] [Abstract][Full Text] [Related]
15. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
Suh JH; Shong M; Choi HS; Lee K
Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
[TBL] [Abstract][Full Text] [Related]
16. An S296R mutation in the human androgen receptor causes activation of the receptor by non-androgenic steroids and stronger inhibition by the nuclear receptor corepressor N-coR.
Li YD; Lu Y; Chen GC; Lu J
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1252-7. PubMed ID: 18637017
[TBL] [Abstract][Full Text] [Related]
17. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
18. [Androgen receptor and SMRT].
Liao GQ; Tang HH; Lü XS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):157-62. PubMed ID: 16145900
[TBL] [Abstract][Full Text] [Related]
19. 5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription.
Sharma M; Sun Z
Mol Endocrinol; 2001 Nov; 15(11):1918-28. PubMed ID: 11682623
[TBL] [Abstract][Full Text] [Related]
20. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
Wang D; Simons SS
Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
